Public disclosures
Page built 2026-09-29
Data as of 2026-09-29
Search

Fresenius Medical Care Corp ADR (FMS): Congress and insider trades

Who in Congress and inside the company traded FMS, when each filing appeared, and what buying after each one would have earned against the S&P 500.

Key Facts

  • Fresenius Medical Care Corp ADR (FMS) is a listed stock on NYSE.
  • 4 members of Congress filed 11 buys and 5 sells of FMS, the latest published 2026-07-21 (21 July 2026).
  • Across 5 scored buys, Congress averaged +0.6% against the S&P 500 (SPY) over the 90 days after disclosure, with 60% of them ahead of the index. That result is too few trades to draw a conclusion.
  • Data as of 2026-09-29 (29 September 2026).
Congress buys 11 4 members
Congress sells 5
Insider buys 0 $0
Insider sells 0 $0
Congress buys vs S&P, 90d +0.6% 5 scored buys
Insider buys vs S&P, 90d n/a 0 scored buys

Congress trades in FMS

as of 2026-07-21
  1. Michael McCaul12 trades
  2. Dean Phillips2 trades
  3. Alan Armstrong1 trade
  4. Daniel S. Goldman1 trade
Congress trades in FMS, newest first.
FiledMemberTypeSizeDays to file90 day vs S&P
21 Jul 2026 Alan Armstrong (R-OK) buy 1K–15K 113 n/a
14 Aug 2023 Daniel S. Goldman (D-NY) sell 1K–15K 34 n/a
14 Oct 2022 Michael McCaul (R-TX) sell 15K–50K 41 n/a
14 Oct 2022 Michael McCaul (R-TX) sell 15K–50K 41 n/a
28 Jan 2022 Michael McCaul (R-TX) sell 1K–15K 44 n/a
28 Jan 2022 Michael McCaul (R-TX) sell 1K–15K 44 n/a
17 Jul 2021 Michael McCaul (R-TX) buy 15K–50K 28 -17.4%
17 Jul 2021 Michael McCaul (R-TX) buy 15K–50K 28 -17.4%
20 Apr 2021 Michael McCaul (R-TX) buy 15K–50K 31 -0.2%
20 Apr 2021 Michael McCaul (R-TX) buy 15K–50K 31 -0.2%
31 Mar 2021 Michael McCaul (R-TX) buy 15K–50K 56 +8.4%
31 Mar 2021 Michael McCaul (R-TX) buy 15K–50K 56 +8.4%
26 Feb 2021 Michael McCaul (R-TX) buy 50K–100K 42 +8.6%
26 Feb 2021 Michael McCaul (R-TX) buy 50K–100K 42 +8.6%
14 Feb 2021 Dean Phillips (D-MN) buy 1K–15K 33 +3.4%
14 Feb 2021 Dean Phillips (D-MN) buy 1K–15K 32 +3.4%

Frequently asked questions

Who has bought FMS?

11 Congress buys by 4 members and 0 insider buys are on file. The tables on this page list every one.

Did buying FMS after a disclosure beat the market?

Across 5 scored buys, Congress averaged +0.6% against the S&P 500 (SPY) over the 90 days after disclosure, with 60% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.

Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.